GlassScriptPhysician profile
Jesse Dylan Chlebeck
NPI 1073879185
$11,101.90
in general payments reported to CMS, 2019-2025
16 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,513 · 2020: $1,464 · 2021: $1,422 · 2022: $419 · 2023: $429 · 2024: $4,565 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,809 · Travel and Lodging: $2,131 · Education: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,808.60 |
| Travel and Lodging | $2,131.23 |
| Education | $344.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,539.82 | 2019-2025 | Persona, Avenir, Rosa |
| Stryker Corporation | $2,366.75 | 2019-2022 | |
| Depuy Synthes Sales INC. | $315.15 | 2019-2025 | Na |
| Medical Device Business Services, INC. | $209.15 | 2019 | |
| Ets Wound Care LLC | $136.50 | 2025 | Mirragen Advanced Wound Matrix |
| Lifenet Health | $119.42 | 2024 | Allograft Vmis Delivery System |
| Medtronic USA, INC. | $114.93 | 2020 | |
| Ferring Pharmaceuticals INC. | $84.38 | 2019-2023 | Euflexxa |
| Encore Medical, LP | $75.15 | 2025 | Djo Surgical |
| Steelhead Surgical INC | $30.04 | 2019-2020 | |
| Heron Therapeutics, INC. | $24.58 | 2023 | Zynrelef |
| Sawtooth Surgical Solutions INC | $22.09 | 2025 | |
| Bioventus LLC | $19.61 | 2023 | Exogen Ultrasound Bone Healing System |
| Total Joint Orthopedics, INC. | $15.00 | 2022 | |
| Osteocentric Technologies, INC. | $14.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $14.47 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Chlebeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.